---
layout: post
title: "千红制药一季度净利润同比增长135.93%"
date: 2022-04-22 19:24:56 +0800
categories: shanghaizhengquanbao·zhongguozhengquanwang
tags: 上海证券报·中国证券网新闻
---
<!-- EM_StockImg_Start --><p style="text-align:center;"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.002550&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 002550_0" data-code="K 002550|0|2" data-code2="K 002550|0|6|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></p><!-- EM_StockImg_End --><p> 千红制药披露一季报。公司2022年第一季度实现营业收入552,220,533.56元，同比增长41.16%；实现归属于上市公司股东的净利润128,247,521.34元，同比增长135.93%；基本每股收益0.1026元/股。</p><p class="em_media">（文章来源：上海证券报·中国证券网）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202204222354358725>

[返回上海证券报·中国证券网新闻](//finews.withounder.com/category/shanghaizhengquanbao·zhongguozhengquanwang.html)｜[返回首页](//finews.withounder.com/)